Briefly, 2 × 106 target 721.221 cells were labelled with 5 μl of the DiO Vybrant cell-labelling solution (Molecular Probes, Carlsbad, CA) in 2 ml PBS for 15 min at room temperature. Target cells were washed twice and plated in R-10 at a final concentration of 25 000 cells per well in U-bottom 96-well plates. Effector cells (either cytokine-treated selleck compound PBMCs or sorted CD8α+ and CD8α− NK
cells) were added at the indicated E : T ratios to a final volume of 200 μl. Plates were incubated at 37° for 4 h. After incubation, cells were labelled with 0·2 μl per well of the far red Live/Dead fixable dead cell stain kit (Invitrogen). Plates were washed twice with PBS and finally fixed in 200 μl of a 2% PBS-paraformaldehyde solution. Labelled cells were stored at −4° until acquisition on a FACSCalibur (BD Biosciences). At least 5000 target cells (FL1-DiO+ events) were acquired. Specific target cell killing was measured by incorporation of the far red LIVE/DEAD
amine dye (FL4) in the DiO+ population. Target cells alone CHIR-99021 in vivo were used as controls to correct for background levels of cell killing. CD4+ T lymphocytes, to be used as target cells, were purified from naive macaque PBMCs using a non-human primate CD4+ T-cell isolation kit (Miltenyi Biotec), labelled with DiO (as described for the 721.221 killing assay), and then coated with 15 μg SIV251 gp120 (ABL) at room temperature for 45 min in RPMI-1640. CD4+ target cells were then washed twice and plated in R-10 at a final concentration
of 10 000 cells per well in U-bottom 96-well plates containing serial dilutions of macaque sera (known to mediate ADCC activity) and incubated for 15 min at room temperature to allow antibody–antigen interaction. Effector cells (autologous PBMCs or sorted CD8α+ and CD8α− NK cells) were added at a 25 : 1 (PBMCs) or 12 : 1 (sorted cells) E : T ratios to a final volume of 200 μl. Plates were centrifuged for 3 min at 400 g to promote cell-to-cell IMP dehydrogenase interactions and then incubated at 37° for 4 hr. After incubation, cells were labelled and analysed as indicated for the 721.221 killing assay. SIV251 gp120-coated target cells alone, ADCC-negative pre-immunization sera from the same macaques, and a no-serum target plus effector cell mixture were used as negative controls. To calculate results, non-specific killing (from target cells alone and from a no-serum target plus effectors mixture) was subtracted from all wells and an ADCC cut-off value was calculated as the mean of values from all dilutions of negative pre-immune sera plus three standard deviations. The ADCC killing was considered positive when killing percentages were higher than the cut-off value. To assess phenotypic stability of macaque NK cell subsets, PBMCs or sorted CD8α+ and CD8α− NK cells were left untreated or were stimulated with IL-2 (400 ng/ml), IL-15 (150 ng/ml), or a combination of both for different time periods.